Adverum Biotechnologies, Inc. (ADVM): Price and Financial Metrics
ADVM Price/Volume Stats
| Current price | $5.41 | 52-week high | $17.65 |
| Prev. close | $4.90 | 52-week low | $3.52 |
| Day low | $4.72 | Volume | 181,300 |
| Day high | $5.42 | Avg. volume | 176,608 |
| 50-day MA | $4.41 | Dividend yield | N/A |
| 200-day MA | $6.36 | Market Cap | 112.54M |
ADVM Stock Price Chart Interactive Chart >
Adverum Biotechnologies, Inc. (ADVM) Company Bio
Adverum Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company was founded in 2006 and is based in Menlo Park, California.
ADVM Price Returns
| 1-mo | 30.99% |
| 3-mo | 14.14% |
| 6-mo | -27.77% |
| 1-year | -64.41% |
| 3-year | -60.22% |
| 5-year | -94.85% |
| YTD | 15.85% |
| 2024 | -37.96% |
| 2023 | 29.91% |
| 2022 | -67.07% |
| 2021 | -83.76% |
| 2020 | -5.90% |
Continue Researching ADVM
Here are a few links from around the web to help you further your research on Adverum Biotechnologies Inc's stock as an investment opportunity:Adverum Biotechnologies Inc (ADVM) Stock Price | Nasdaq
Adverum Biotechnologies Inc (ADVM) Stock Quote, History and News - Yahoo Finance
Adverum Biotechnologies Inc (ADVM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...